Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes
about
Papillomavirus Infectious Pathways: A Comparison of SystemsVLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirusTranslocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosisMechanisms of cell entry by human papillomaviruses: an overview.The role of furin in papillomavirus infection.Study of infectious virus production from HPV18/16 capsid chimeras.Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections.Papillomavirus infection requires gamma secretase.Efficient delivery of DNA vaccines using human papillomavirus pseudovirionsOvarian cancer gene therapy using HPV-16 pseudovirion carrying the HSV-tk genePapillomavirus capsid proteins mutually impact structureDNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunityIdentification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody.Second-generation prophylactic HPV vaccines: successes and challenges.Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17.Opposing effects of bacitracin on human papillomavirus type 16 infection: enhancement of binding and entry and inhibition of endosomal penetrationInfluence of physiologic folate deficiency on human papillomavirus type 16 (HPV16)-harboring human keratinocytes in vitro and in vivo.Interaction of human papillomavirus type 16 particles with heparan sulfate and syndecan-1 molecules in the keratinocyte extracellular matrix plays an active role in infection.Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy.Influence of oxidation and multimerization on the immunogenicity of a thioredoxin-l2 prophylactic papillomavirus vaccineFurin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on CyclophilinsL2, the minor capsid protein of papillomavirus.Role of L2 cysteines in papillomavirus infection and neutralizationViral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus.Host-cell factors involved in papillomavirus entry.Principles of polyoma- and papillomavirus uncoating.Human papillomavirus: current status and issues of vaccination.Coat as a dagger: the use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking.A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection.Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteinesHuman papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive.PhiXing-it, displaying foreign peptides on bacteriophage ΦX174.HPV pseudovirions as DNA delivery vehicles.
P2860
Q26801497-C4580EA1-06A2-449E-994B-0CB8A5734603Q28280059-5154FE2F-AF04-4DC6-A1C4-AFFF94B39E0FQ33626389-B6E91073-01D8-4C50-85A5-12D12312FA71Q33663169-5622617E-6212-461F-B50F-AACEE312873CQ33693739-EB495214-A95C-4D2E-A3C6-A7712F3C217DQ34071813-6AC08B29-3892-46E5-A9F5-F04E23BC811EQ34162277-8E6839F3-9377-4E5E-B556-40EAD9BFC90EQ34178325-11DF5C41-749C-4694-8A4F-3E82661611D9Q34274080-02F7F2F1-B90F-4AF4-BDC6-5ED30C2654F6Q34345491-233E405F-A189-4113-8D6E-1B5C240CBE81Q34699403-350595B2-0855-45AD-BD28-DC8142FA6B8BQ35184078-A2D85609-1489-4C99-8E78-5D16673D1E66Q35532771-7F547B2F-E97B-40E0-AD11-F0356F93B68DQ35541886-47981698-0166-46C3-BA9F-D937DE61CB83Q35748557-113453F3-D36C-4BC1-8B80-10BF60BD9097Q35868083-93BEB5E0-24AB-4B1A-A0D5-13E9F674D350Q35874563-62214322-CF5F-4D12-A394-2614EBEE498FQ36376623-0C6728D4-03E1-4EC4-BEF2-C668BE9DA100Q36607050-541EBC66-E820-4ACA-8B01-15246B226D14Q36970255-0758F04D-62F1-4C63-8948-9A9CCD581B16Q37073350-9988D76A-A88B-4AC2-AD86-CAF0B02E9C35Q37164879-D2C125DF-AE1A-47FF-BD88-ACC5605C5F2AQ37410946-756196C6-9B5A-48D9-8536-475BE6F2A9D1Q37480444-DB3BBD7C-1D65-4262-89BE-8950665DE18DQ38042837-675A518E-794B-48D2-975F-FF9D9A306978Q38045782-CDD744E2-F12F-471D-92A0-709DE583E6D5Q38136127-920A5E29-0325-4603-B378-801AFB430593Q38233232-8CA8BD53-E6A7-4FFB-80C7-0703AA49E74AQ39253672-B8CA982E-DE6C-4FA5-BA45-2D4D7FC3E577Q39803010-DFDC3228-B62B-488F-BE2F-930408F556D3Q39843190-48776FC6-C0F0-4830-8881-54FF9930B36DQ40876140-AB88210D-3564-4615-A465-381F0E49FB6CQ42010237-E8F6CE71-E785-416F-AC74-081866604780
P2860
Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Two highly conserved cysteine ...... ctivity in human keratinocytes
@ast
Two highly conserved cysteine ...... ctivity in human keratinocytes
@en
Two highly conserved cysteine ...... ctivity in human keratinocytes
@en-gb
Two highly conserved cysteine ...... ctivity in human keratinocytes
@nl
type
label
Two highly conserved cysteine ...... ctivity in human keratinocytes
@ast
Two highly conserved cysteine ...... ctivity in human keratinocytes
@en
Two highly conserved cysteine ...... ctivity in human keratinocytes
@en-gb
Two highly conserved cysteine ...... ctivity in human keratinocytes
@nl
altLabel
Two Highly Conserved Cysteine ...... ctivity in Human Keratinocytes
@en
prefLabel
Two highly conserved cysteine ...... ctivity in human keratinocytes
@ast
Two highly conserved cysteine ...... ctivity in human keratinocytes
@en
Two highly conserved cysteine ...... ctivity in human keratinocytes
@en-gb
Two highly conserved cysteine ...... ctivity in human keratinocytes
@nl
P2860
P1433
P1476
Two highly conserved cysteine ...... ctivity in human keratinocytes
@en
P2860
P356
10.1371/JOURNAL.PONE.0004463
P407
P577
2009-01-01T00:00:00Z